The company maintains that it is not moving to oust Pfizer’s vaccine from the market nor is it seeking to prevent future sales of its vaccine.
The biotech giant said planned to invest up to $500 million in the East African country.
“Until such vaccines are available, and as the SARS-CoV-2 virus evolves, the composition of current COVID-19 vaccines may need to be updated…”
A dose of COVID-19 booster gives greater protection against the virus, the government said.
This delivery is the second batch of vaccines to arrive in the country, after four million doses were delivered in March under the COVAX vaccine sharing facility.
About three million people would be inoculated before the end of March.
Despite lacking scientific literacy, the Kogi governor also expressed doubts about the speed with which scientists came up with COVID-19 vaccines.
Nigeria has recorded over 105,000 cases and over 1,400 coronavirus deaths.
